CNBC Investing Club

Cramer's Investing Club Profile: Eli Lilly has one of best pipelines in the drug industry

David Ricks, CEO, Eli Lilly
Scott Mlyn | CNBC

We think Eli Lilly (LLY) is one of the highest-quality drug companies in the market.

More In CNBC Investing Club Newsletter

CNBC Investing ClubNew analyst reports support our view of Constellation as a great defensive play
CNBC Investing ClubWall Street notes on Apple, Qualcomm highlight the long-term opportunities in those stocks
CNBC Investing ClubTuesday's market bounce allows us to raise some cash to buy in the next downturn